- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Bioinorganic Chemistry and Applications
Volume 2010 (2010), Article ID 323152, 7 pages
Zinc Binding Properties of Engineered RING Finger Domain of Arkadia E3 Ubiquitin Ligase
Department of Pharmacy, University of Patras, Panepistimioupoli, Rion, 26504 Patras, Greece
Received 15 March 2010; Accepted 12 May 2010
Academic Editor: Spyros P. Perlepes
Copyright © 2010 Christos T. Chasapis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Human Arkadia is a nuclear protein consisted of 989 amino acid residues, with a characteristic RING domain in its C-terminus. The RING domain harbours the E3 ubiquitin ligase activity needed by Arkadia to ubiquitinate its substrates such as negative regulators of TGF- signaling. The RING finger domain of Arkadia is a RING-H2 type and its structure and stability is strongly dependent on the presence of two bound Zn(II) ions attached to the protein frame through a defined Cys3-His2-Cys3 motif. In the present paper we transform the RING-H2 type of Arkadia finger domain to nonnative RING sequence, substituting the zinc-binding residues or to Arginine, through site-directed mutagenesis. The recombinant expression, in Escherichia coli, of the mutants C955R and H960R reveal significant lower yield in respect with the native polypeptide of Arkadia RING-H2 finger domain. In particular, only the C955R mutant exhibits expression yield sufficient for recombinant protein isolation and preliminary studies. Atomic absorption measurements and preliminary NMR data analysis reveal that the C955R point mutation in the RING Finger domain of Arkadia diminishes dramatically the zinc binding affinity, leading to the breakdown of the global structural integrity of the RING construct.
RING finger is a characteristic protein sequence motif that was first identified in the protein product of the human gene RING1—Really Interesting New Gene 1—which is located proximal to the major histocompatibility region on chromosome 6 . The RING finger domain is a cysteine/histidine-rich, zinc-chelating domain that promotes both protein-protein and protein-DNA interactions . It is defined as Cys1-Xaa2-Cys2--Cys3--His4--Cys/His5-Xaa2-Cys6--Cys7-Xaa2-Cys8 (where Xaa can be any amino acid residue). Two zinc atoms are complexed by the cysteine/histidine residues in a “cross-brace” manner, to provide correct folding and biological activity to the RING domain Figure 1(a) [3, 4]. The distinctive cross-brace arrangement of the two tetrahedral zinc binding sites endows the RING domain with a globular conformation, characterized by a central α-helix and variable-length loops separated by several small -strands. RING finger motifs are further subdivided, depending on whether a cysteine or histidine residue is found at Cys/His5 within the motif. Thus they are classified as being either a RING-HC (Cys5) or a RING-H2 (His5) type. The metal binding properties of some RING finger domains have been investigated in a preliminary manner, using synthetic peptides that bear the amino acid sequence of BRCA1 and HDM2 [5, 6]. It is well-established that RING fingers can also bind other than zinc metal ions, such as cobalt (II) and cadmium (II) [7–9]
Human Arkadia is a nuclear protein of 994 amino acid open reading frame (ORF) that exhibits no sequence similarity with any other known protein apart from the RING-H2 finger topology in its C-terminal region . Mouse Arkadia ORF differs in length by 5 residues (989 aa) but their C-terminal 124 residue segments bear identical amino acid sequence. Arkadia has been shown to function as an E3 ubiquitin ligase . E3 ligases participate actively at the last step of the protein degradation through the ubiquitination pathway [12, 13]. Additionally, RING E3 ubiquitin ligases play an essential role in the regulation of many biological processes and defects in some of them are involved in cancer development. Thus, RING E3 ligases represent a potential molecular target for disease intervention in mechanism-driven drug discovery [14–17]. Arkadia is the first example of a RING E3 ubiquitin ligase that positively regulates TGF- family signaling. The RING-H2 domain harbours the E3 ubquitin ligase activity required by Arkadia to ubiquitinate various negative regulators of TGF- [11, 18–20]. Recently an efficient method for expression in Escherichia coli and purification of recombinant Arkadia RING-H2 finger domain as a soluble protein was reported . Preliminary NMR data analysis of the Arkadia RING Finger suggests a -like topology typical of RING finger domains. Additionally, NMR experimental evidence indicates that proper zinc incorporation is a major determinant for the RING finger domain structure and stability .
Each type of RING domain exhibits unique structural characteristics, which may affect the specificity of the recruitment of E2 enzymes or substrate recognition. Furthermore, substitution of various native amino acids, especially the zinc-binding residues, resulted in the significant loss of ubiquitination capacity, as shown in various E3 ligases such as BRCA1, HDM2 and many other RING finger domain-containing proteins. Substitution of zinc-binding amino acids with residues by atom-donors with lower affinity to zinc metal ion, results in a collapsed RING finger structure or in a conformational alteration that prevents RING from interacting with E2. Thus assembly of E2 and E3 into a productive complex, a key component in the ubiquitination pathway, is misformed. Herein we present the production of two nonnative RING finger domains of mouse Arkadia: C955R and H960R Figure 1(b), through site-directed mutagenesis. The recombinant expression in Escherichia coli of the mutants C955R and H960R reveals significant lower yield in respect with the native polypeptide of Arkadia RING-H2 finger domain. Only the C955R mutant exhibits expression yield sufficient for recombinant protein isolation and the protocol applied was based on that used for the wt of Arkadia RING-H2 finger domain . Since zinc binding is considered to be critical to proper folding and activity of the RING-H2 domain of Arkadia, the nonnative polypeptides were expressed in zinc-loaded growth media. Zinc contents of the wt and mutant C955R RING construct were determined by Atomic Absorption measurements. Finally, the folding state and the structural integrity of the holo-RING constructs were monitored through 1H and 2D 1H-15N-HSQC spectroscopy.
2. Materials and Methods
2.1. Plasmids, Bacterial Strains, and Growth Media
E. coli DH5α (Invitrogen) was used as the host strain for cloning and plasmid propagation and E. coli BL21(DE3) (Stratagene) as the host strain for the expression vector pGEX–4T-1 (Amersham Biosciences). Both strains were routinely grown in Luria-Bertani (LB hereafter) broth or on plates of LB agar, supplemented with ampicillin (100 g/ml) for both transformed DH5 and BL21(DE3) strains. Induction was carried out in M9 medium supplemented with 2 ml/l of solution Q (40 mM HCl, 50 mg/l FeCl24H2O, 184 mg/l CaCl22H2O, 64 mg/l H3BO3, 18 mg/l CoCl26H2O, 340 mg/l ZnCl2, 605 mg/l Na2Mo42H2O, 40 mg/l MnCl24H2O) and 10 ml/l of vitamin mix (500 mg/l thiamine, 100 mg/l biotin, 100 mg/l choline chloride, 100 mg/l folic acid, 100 mg/l niacinamide, 100 mg/l pantothenic acid, 100 mg/l pyridoxal, 10 mg/l riboflavin).
2.2. Cloning, Expression, Purification, and Isotopic Labeling of Arkadia RING Constructs
The protocol adopted to express and purify the nonnative RING constructs of Arkadia was essentially the same as that previously reported to produce the wt of the RING-H2 construct . The expression plasmids for the presented mutants were obtained from that of wt RING-H2 through the Quickchange (Stratagene) mutagenesis kit. 15N isotopic labeling of the mutant C955R was obtained using M9 medium supplemented with 2 g/l 15NH4Cl as nitrogen source.
2.3. Preliminary Protein Characterization
The purity of all polypeptides was checked by SDS-PAGE in 17% polyacrylamide gels after staining of protein bands with Coomassie Blue R-250. The concentration of RING domains of Arkadia was determined by using two methods: the first is based on the extinction coefficients at 280 nm of each construct, as estimated by PROTPARAM software (http://www.expasy.org/tools/protparam.html/) and the second, which is more accurate, on the Quick start Bradford protein assay (BIORAD) .
2.4. Atomic Absorption Spectrometry
Elemental analysis for zinc was performed employing Atomic Absorption Spectrometry (Perkin Elmer AAnalyst 300). The zinc content was measured in wt RING-H2 and the mutant C955R RING constructs. In order to exclude any matrix effect in zinc measurements, the standard addition method was applied . Four samples were prepared for the first construct, the unspiked and three aliquots (spiked) to which known amounts of the analyte zinc from a stock standard solution (AA Panreac g/l Zn) were added (Table 1). For the nonnative construct, three samples were prepared, respectively: the unspiked and two spiked. The spiked concentration ranged from 0 (unspiked sample) to 0.6 ppm. The volume was kept equal for all samples by means of addition of PBS buffer. Preliminary tests assured that the overall concentration of zinc was lying within the linear range of the technique (1 ppm). Absorbance of all samples at the appropriate wavelength (213.9 nm) was measured twice. An appropriate calibration curve for each protein was constructed (Table 3, Figure 3). The concentration of zinc in the unspiked samples was determined, dividing the intercept by the slope of calibration curve .
2.5. NMR Spectroscopy
1D 1H-NMR and 1H-15N HSQC spectra were recorded at 298 K on a Bruker Avance 600 MHz spectrometer, equipped with a cryogenically cooled pulsed-field gradient triple-resonance probe (TXI) and on a Bruker Avance DRX 400 MHz, equipped with two multinuclear broadband probes (inverse BBI and direct BBO). 1H 1D spectra were acquired in the 16 ppm spectral width using a variety of pulse sequence for water suppression and spectra were calibrated relatively to the water proton resonances. The 2D 15N HSQC spectra were acquired using a spectral width of 40 ppm for 1 and 8 ppm for 2. The NMR samples contained 1 mM and 0.2 mM protein of wt Arkadia and mutant construct C955R, respectively, in 50 mM phosphate buffer, , in the presence of 90% H2O/10% D2O.
3. Results and Discussion
The C-terminal RING finger domains of wt and Arkadia mutants were expressed in M9 minimal growth media supplemented with ZnCl2. Both of the mutants: C955R and H960R, reveal remarkably lower expression yield in respect with the native polypeptide of Arkadia RING-H2 finger domain. Small-scale test expression of RING constructs in the absence of ZnCl2 suggests that additional zinc enrichment of growth media does not affect the expression yield of soluble RING constructs. In Figure 2, it is presented the total cell lysate of wt (a), the mutant C955R (b) and H960R (c), at C with ZnCl2 at a final concentration 100 M. Finally, from the above mutants, the expression yield of the C955R mutant was sufficient for recombinant protein isolation and preliminary studies.
Elemental analysis for zinc was performed employing Atomic Absorption Spectrometry. A calibration curve for each protein sample (Figure 3) was constructed as described in Section 2. The concentration of zinc in the unspiked sample of both constructs was determined, dividing the intercept by the slope of the calibration curves  (Table 3). The concentration of zinc in the initial samples of 0.5 mM RING-H2 and 0,2 mM C955R mutant of Arkadia was calculated to be 1 mM and 0 mM, respectively, (Table 2). It should, also, be stressed that the zinc content of the constructs remained stable in excess of ZnCl2 in the growth media (100 ). The atomic absorption measurements of the native RING construct suggest a stoichiometry of two zinc ions per molecule, a value that is in agreement with the classic binding properties of RING fingers. However, the elemental analysis of the C955R mutant suggests that the mutated construct does not bind zinc at all, indicating that the substitution of one of the three cysteines in the second tetrahedral zinc binding motif abolishes the global metal binding capacity of the hole polypeptide.
It is known that the protein structure of the Arkadia zinc loaded wt RING-H2 domain is well folded and the zinc incorporation is a major determinant for its structure and stability [17–21]. Indeed, when EDTA was added to a sample of the Arkadia RING finger domain at a 1 : 1 molar ratio with respect to Zn(II) substantial changes were observed for a number of residues in a 1H-15N HSQC spectrum. Further addition of EDTA up to a final Zn : EDTA molar ratio of 1 : 2 led to dramatic changes in the 1H-15N HSQC typical for structureless polypeptide . The 1D 1H-NMR spectrum of C955R mutant (Figure 4(a)) and its comparison with the 1D NMR spectrum of the wt (Figure 4(b)) suggests that the C955R RING construct is not a folded protein.
Heteronuclear NMR spectroscopy, and especially 2D 1H-15N-HSQC experiments provides the fingerprint spectrum of each polypeptide and are diagnostic tools for the folding properties and aggregation state of recombinant proteins. Additionally, this technique can probe fine structural rearrangements upon amino acids substitutions and for this reason it is applied to probe the effect of C955R mutation. Indeed, the 1H-15N-HSQC exhibits dramatic changes in respect with the spectrum of the native RING construct, with no signal dispersion of the backbone amide groups (Figure 4). This remarkable lack of the chemical shift dispersion is almost identical to that observed in the HSQC spectrum of the unstructured wt RING construct, due to the presence of EDTA excess . EDTA is a powerful metal chelating agent and competes the RING polypeptide for zinc binding. Excess of EDTA in RING Finger solution uptakes the zinc ion and RING polypeptide structure collapses as evidenced by the HSQC. Mutation of the Cys955 by Arg seems to result to an unstructured polypeptide that has abolished the zinc binding ability.
The substitution of the His960 and Cys955 residues by an Arg was driven by the fact that Arg, according to Blosum matrix, is among the residues with the higher probability to substitute His in polypeptide sequence, due to the similar length and nature of its side chain and its basic character. Additionally, its linear side-chain is not expected to impose significant steric interaction that may alter dramatically the spatial geometry of the other potential Zn(II) binding residues (three Cysteines). Since the expression yield of the H960R mutant was very low for protein isolation, preliminary studies were performed only for the C955R mutant. It is proposed that the new mutated motif does not bind zinc at all, in contrast to the stoichiometry of two zinc ions per molecule for the native RING construct. Although the alteration occurred in the second binding motif, both binding sites are losing their metal binding capacity. Additionally, NMR spectroscopy indicates that C955R mutant of RING Arkadia undergoes significant structural rearrangements losing its proper folding, in respect with the native polypeptide. This result may provide new insights into the sequential metal loading by the two tetrahedral binding sites of the RING-H2 domain of Arkadia. Since the net effect of the C955R substitution is the collapse of the structure it is suggested that the second site may be an important regulator that affects the formation of the first site and the overall metal-dependent folding of the polypeptide. In the past, the sequential binding was considered to be a general characteristic of RING finger domains, but its biological significance has not yet been established [5, 24, 25]. One characteristic example is the metal binding properties of peptide corresponding to the RING finger domain from the tumor suppressor gene product BRCA1. It is found that the above metal binding is thermodynamically sequential with cobalt(II) almost saturating one of the two sites in each polypeptide prior to binding to the other site. Analysis of the absorption spectra due to cobalt(II) bound to the two sites revealed that the higher affinity site is comprised of four cysteinate ligands whereas the lower affinity site has three cysteinate and one histidine ligands. Upon binding a metal ion to site 1 (Cys4), the peptide becomes somewhat more structured and, perhaps, more rigid in a manner that affects the regions involved in forming site 2 (Cys3His). This, in turn, increases the difficulty in binding a metal ion to site 2, leading to the observed anticooperativity . The same metal binding properties were found in the RING finger domain of HDM2 C-terminal domain. In this case the metal binds to the higher-affinity binding site were monitored through fluorescence energy transfer, revealing two binding events separately: the stronger binding site C4 and the weaker one C3H. Furthermore, synthetic knockout mutants not only enabled to assign the coordinating residues in the HDM2 RING finger domain but also revealed that metal binding to HDM2 was also anticooperative .
In summary, we reinforce the theory that substitution of zinc-binding amino acids in RING finger domains may possesses an immense role in the biochemical and biological activity of RING Finger E3 ligases. Herein, we demonstrate that even one point mutation (C955R) in the RING finger domain of Arkadia can have a dramatic effect in the domain structure, leading to the breakdown of the global structural integrity of the RING construct. This phenomenon is expected to prevent the formation of a E3-E2 productive complex and finally to reduce its ubiquitin ligase activity. In the past, similar results have been reported regarding mutants in the zinc binding motif of HDM2 (429–491). RING finger domain (such as His452Ala and His457Ala) was studied through NMR spectroscopy revealing a lack of dispersion and broad resonances in 15N-HSQC spectra, characteristic of unfolded protein . The correlation between mutations in the RING finger domain of E3 ligases and their ubiquitination activity was well established in the past through the detection of mutations within the BRCA1 RING domain that predispose to cancer due to the abolishment of BRCA1 ligase activity . Furthermore, site mutations in the RING finger of E3 ligases are associated with various consequences in biological processes such as their unusual distribution in the cell, like the large cytoplasmic and nuclear inclusion of the two mutant isoforms of Parkin RING finger protein . In this light, the verification of this probable occurrence of a sequential metal binding by the wt/mutant of RING finger domains of Arkadia and the study of their mechanism remain to be done.
|RING:||Really interesting new gene|
|TGF-||Transforming growth factor|
|NMR:||Nuclear Magnetic Resonance.|
G. Spyroulias and C. Chasapis wish to thank Dr. Vasso Episkopou for kindly providing the plasmid containing full length of Arkadia, EU-NMR program Grant no. RII3-026145 (CERM; Center of Magnetic Resonance, University of Florence) and Center of Instrumental Analysis of University of Patras for access to NMR instrumentation. G. Spyroulias also acknowledges a Research Committee, “K. Karatheodori” Research Grant (No. C.181).
- P. S. Freemont, “The RING finger. A novel protein sequence motif related to the zinc finger,” Annals of the New York Academy of Sciences, vol. 684, pp. 174–192, 1993.
- P. S. Freemont, “RING for destruction?” Current Biology, vol. 10, no. 2, pp. R84–R87, 2000.
- K. L. B. Borden and P. S. Freemont, “The RING finger domain: a recent example of a sequence-structure family,” Current Opinion in Structural Biology, vol. 6, no. 3, pp. 395–401, 1996.
- A. J. Saurin, K. L. B. Borden, M. N. Boddy, and P. S. Freemont, “Does this have a familiar RING?” Trends in Biochemical Sciences, vol. 21, no. 6, pp. 208–214, 1996.
- P. C. Roehm and J. M. Berg, “Sequential metal binding by the RING finger domain of BRCA1,” Biochemistry, vol. 36, no. 33, pp. 10240–10245, 1997.
- Z. Lai, D. A. Freedman, A. J. Levine, and G. L. McLendon, “Metal and RNA binding properties of the hdm2 RING finger domain,” Biochemistry, vol. 37, no. 48, pp. 17005–17015, 1998.
- R. Lovering, I. M. Hanson, and I. M. Hanson, “Identification and preliminary characterization of a protein motif related to the zinc finger,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 6, pp. 2112–2116, 1993.
- A. G. Von Arnim and X.-W. Deng, “Ring finger motif of Arabidopsis thaliana COP1 defines a new class of zinc-binding domain,” The Journal of Biological Chemistry, vol. 268, no. 26, pp. 19626–19631, 1993.
- C. Upton, L. Schiff, S. A. Rice, T. Dowdeswell, X. Yang, and G. McFadden, “A poxvirus protein with a RING finger motif binds zinc and localizes in virus factories,” Journal of Virology, vol. 68, no. 7, pp. 4186–4195, 1994.
- V. Episkopou, R. Arkell, P. M. Timmons, J. J. Walsh, R. L. Andrew, and D. Swan, “Induction of the mammalian node requires Arkadia function in the extraembryonic lineages,” Nature, vol. 410, no. 6830, pp. 825–830, 2001.
- K. J. Mavrakis, R. L. Andrew, and R. L. Andrew, “Arkadia enhances Nodal/TGF-beta signaling by coupling phospho-Smad2/3 activity and turnover,” PLoS Biology, vol. 5, no. 3, article e67, 2007.
- A. Hershko and A. Ciechanover, “The ubiquitin system,” Annual Review of Biochemistry, vol. 67, pp. 425–479, 1998.
- J. Adams, “The proteasome: structure, function, and role in the cell,” Cancer Treatment Reviews, vol. 29, no. 1, pp. 3–9, 2003.
- M. Lakshmanan, U. Bughani, S. Duraisamy, M. Diwan, S. Dastidar, and A. Ray, “Molecular targeting of E3 ligases-a therapeutic approach for cancer,” Expert Opinion on Therapeutic Targets, vol. 12, no. 7, pp. 855–870, 2008.
- T. R. Pray, F. Parlati, and F. Parlati, “Cell cycle regulatory E3 ubiquitin ligases as anticancer targets,” Drug Resistance Updates, vol. 5, no. 6, pp. 249–258, 2002.
- Y. Sun, “Targeting E3 ubiquitin ligases for cancer therapy,” Cancer Biology & Therapy, vol. 2, no. 6, pp. 623–629, 2003.
- C. T. Chasapis and G. A. Spyroulias, “RING finger E3 ubiquitin ligases: structure and drug discovery,” Current Pharmaceutical Design, vol. 15, no. 31, pp. 3716–3731, 2009.
- D. Koinuma, M. Shinozaki, and M. Shinozaki, “Arkadia amplifies TGF-β superfamily signalling through degradation of Smad7,” The EMBO Journal, vol. 22, no. 24, pp. 6458–6470, 2003.
- L. Levy, M. Howell, D. Das, S. Harkin, V. Episkopou, and C. S. Hill, “Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation,” Molecular and Cellular Biology, vol. 27, no. 17, pp. 6068–6083, 2007.
- Y. Nagano, K. J. Mavrakis, and K. J. Mavrakis, “Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-β signaling,” The Journal of Biological Chemistry, vol. 282, no. 28, pp. 20492–20501, 2007.
- N. G. Kandias, C. T. Chasapis, V. Episkopou, D. Bentrop, and G. A. Spyroulias, “High yield expression and NMR characterization of Arkadia E3 ubiquitin ligase RING-H2 finger domain,” Biochemical and Biophysical Research Communications, vol. 378, no. 3, pp. 498–502, 2009.
- M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976.
- D. A. Skoog, F. J. Holler, and T. A. Nieman, Principles of Instrumental Analysis, Brooks Cole, Florence, Ky, USA, 5th edition, 1997.
- K. L. B. Borden, M. N. Boddy, and M. N. Boddy, “The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML,” The EMBO Journal, vol. 14, no. 7, pp. 1532–1541, 1995.
- A. G. von Arnim and X.-W. Deng, “Ring finger motif of Arabidopsis thaliana COP1 defines a new class of zinc-binding domain,” The Journal of Biological Chemistry, vol. 268, no. 26, pp. 19626–19631, 1993.
- M. Kostic, T. Matt, M. A. Martinez-Yamout, H. J. Dyson, and P. E. Wright, “Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53,” Journal of Molecular Biology, vol. 363, no. 2, pp. 433–450, 2006.
- H. Ruffner, C. A. P. Joazeiro, D. Hemmati, T. Hunter, and I. M. Verma, “Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5134–5139, 2001.
- M. R. Cookson, P. J. Lockhart, C. McLendon, C. O'Farrell, M. Schlossmacher, and M. J. Farrer, “RING finger 1 mutations in Parkin produce altered localization of the protein,” Human Molecular Genetics, vol. 12, no. 22, pp. 2957–2965, 2003.